Oscar Health Inc. (NYSE: OSCR) reported Q3 EPS of ($0.29), $0.20 better than the analyst estimate of ($0.49). Revenue for the quarter came in at $1.43 billion versus the consensus estimate of $1.41 billion.

For earnings history and earnings-related data on Oscar Health Inc. (OSCR) click here.